Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Takes $10M in Stimulus Orders

NEW YORK (GenomeWeb News) – Bruker said this week that it has taken in $10 million in orders due to stimulus programs in the US, Japan, and Europe.

The firm disclosed in a filing with the US Securities and Exchange Commission that by the end of August it had booked $10 million in orders due the various stimulus programs, with more than $3 million coming from Japan. It said that it had booked five system orders from that country.

In addition, Bruker said that it expected "significant" NMR, MRI, EPR, X-ray crystallography, high-end mass spectrometry, and other system orders during the third and fourth quarters of this year, and into 2010, due to the global stimulus programs.

Bruker also disclosed this information during a presentation this week at a Morgan Stanley institutional investors' conference in Zurich, Switzerland.

"We are encouraged by these orders and believe they will be a key driver f possible upside surprise in BRKR revenues," Leerink Swann analyst Isaac Ro wrote in a research note published today.

The Scan

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.